11+ hour, 45+ min ago   (1410+ words) 25 July 2026 | Saturday | Analysis One caveat before the table. This is not the APAC Bioeconomy Index, which is a separate benchmark with its own methodology and a different purpose. This is a siting-decision comparison written for people choosing where to put…...

2+ day, 4+ hour ago   (137+ words) 24 July 2026 | Friday | News Tikva Allocell Pte. Ltd. ("Tikva"), a biotechnology company developing engineered, allogeneic (donor-derived) cell therapies for adult and pediatric patients with solid tumors, today announced the closing of an $8 million Series A financing led by Kantharos Capital. Proceeds…...

2+ day, 4+ hour ago   (87+ words) 24 July 2026 | Friday | News Under the agreement, MedUni Vienna is granted the right to use Nona's technology for antibody generation and to further develop the resulting antibodies and antibody products for research, diagnostic, and therapeutic applications. The H2L2 Harbour Mice® platform and…...

2+ day, 22+ hour ago   (258+ words) BioPharma APAC - GHIT Fund Invests JPY 140M to Accelerate Portable Rapid Diagnostic System for Ebola 23 July 2026 | Thursday | News This investment covers approved early development milestones, including prototype development and performance validation for Bundibugyo virus detection, and supports preparations for future clinical…...

3+ day, 1+ hour ago   (306+ words) 23 July 2026 | Thursday | Analysis Both stories are told by serious people. Both are partly true. This piece sets out to separate the part of the price that is risk from the part that is reputation, and to be honest about where…...

2+ day, 22+ hour ago   (156+ words) 23 July 2026 | Thursday | News Ÿ Under the agreement, Samsung Bioepis will obtain exclusive commercial licensing rights to SBE303, an ADC candidate currently in joint development Ÿ This agreement marks the first commercial license agreement to be signed between the two parties under…...

3+ day, 1+ hour ago   (306+ words) 23 July 2026 | Thursday | Analysis Both stories are told by serious people. Both are partly true. This piece sets out to separate the part of the price that is risk from the part that is reputation, and to be honest about where…...

3+ day, 10+ hour ago   (235+ words) 23 July 2026 | Thursday | News The NSG Bio Tomorrow initiative aims at supporting emerging life sciences startups working on complex challenges in respiratory and neonatal care. The selected startup will gain access to NSG Bio's laboratory infrastructure, shared workspaces, meeting facilities, and…...

3+ day, 23+ hour ago   (557+ words) 22 July 2026 | Wednesday | Analysis Own operations. Amgen (2027) · Eli Lilly · Gilead Sciences · Boehringer Ingelheim · Bayer · GSK (net-zero climate impact) Operations or full value chain. Takeda (operations before 2035, value chain before 2040) · Novartis · Pfizer · Biogen (operations) · Eisai · Bristol Myers Squibb Full value chain. Novo…...

4+ day, 2+ min ago   (103+ words) 22 July 2026 | Wednesday | News Cosela® is currently marketed in the United States and China and is under registration in Europe. Subject to regulatory approvals, the first Asia-Pacific launch is anticipated in Hong Kong in 2028, followed by other markets thereafter. The partnership…...